Citizens maintains Market Outperform rating on ACADIA Pharmaceuticals, $33 price target

Citizens maintained their Market Outperform rating on ACADIA Pharmaceuticals's stock with a price target of $33.00.The price target implies an upside of 48.8% from the Sep 24 close of $22.18.Key takeaways from the analyst noteStrong Clinical Results in Psychosis Treatment: ACADIA Pharmaceuticals de…